MULTIFUNCTIONAL NATURAL KILLER CELL ENGAGER RELEASING CXCL10 AUGMENTS NATURAL KILLER CELL RECRUITMENT AND ANTI-TUMOR EFFICACY AGAINST GLIOBLASTOMA

被引：0
|
作者：
Yao, Xue [1 ]
Matosevic, Sandro [1 ]
机构：
[1] Purdue Univ, Lafayette, IN USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2022年 / 10卷
关键词：
D O I：
10.1136/jitc-2022-SITC2022.1018
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1018
引用
收藏
页码：A1061 / A1061
页数：1
相关论文
共 50 条
  • [21] CDK4/6 inhibition augments anti-tumor efficacy of XPO1 inhibitor selinexor in natural killer/T-cell lymphoma
    Wang, Yali
    Chen, Jianfeng
    Gao, Yan
    Chai, Kelila Xin Ye
    Hong, Jing Han
    Wang, Peili
    Chen, Jinghong
    Yu, Zhaoliang
    Liu, Lizhen
    Huang, Cheng
    Taib, Nur Ayuni Muhammad
    Lim, Kerry May Huifen
    Guan, Peiyong
    Chan, Jason Yongsheng
    Huang, Dachuan
    Teh, Bin Tean
    Li, Wenyu
    Lim, Soon Thye
    Yu, Qiang
    Ong, Choon Kiat
    Huang, Huiqiang
    Tan, Jing
    CANCER LETTERS, 2024, 597
  • [22] Prospective Molecular Targets for Natural Killer Cell Immunotherapy against Glioblastoma Multiforme
    Cooksey, Luke C.
    Friesen, Derek C.
    Mangan, Enrique D.
    Mathew, Porunelloor A.
    CELLS, 2024, 13 (18)
  • [23] Cytokines impact natural killer cell phenotype and functionality against glioblastoma in vitro
    Sivonen, Minna
    Sirvio, Katja A.
    Wojciechowski, Sara
    Kailaanmaki, Anssi
    Kaipainen, Satu
    Bailey, Aubrey
    Villalba, Martin
    Kekarainen, Tuija
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [24] TARGETING A SHARED GLIOBLASTOMA CELL STATE THROUGH ADAPTIVE NATURAL KILLER CELLS AUGMENTED WITH TRISPECIFIC KILLER CELL ENGAGER (TRIKE) IMMUNE-MODULATOR AGAINST CD276
    Ning, Jianfang
    Davis, Zachary
    Zhu, Shan
    Miller, Jeffrey
    Chen, Clark
    NEURO-ONCOLOGY, 2023, 25
  • [25] New developments in anti-tumor efficacy and malignant transformation of human natural killer cells
    VanDeusen, JB
    Caligiuri, MA
    CURRENT OPINION IN HEMATOLOGY, 2003, 10 (01) : 55 - 59
  • [26] Adoptive transfer of natural killer cells promotes the anti-tumor efficacy of T cells
    Goding, Stephen R.
    Yu, Shaohong
    Bailey, Lisa M.
    Lotze, Michael T.
    Basse, Per H.
    CLINICAL IMMUNOLOGY, 2017, 177 : 76 - 86
  • [27] Bortezomib Augments Natural Killer Cell Targeting of Stem-Like Tumor Cells
    Luna, Jesus I.
    Grossenbacher, Steven K.
    Sturgill, Ian R.
    Ames, Erik
    Judge, Sean J.
    Bouzid, Lyes A.
    Darrow, Morgan A.
    Murphy, William J.
    Canter, Robert J.
    CANCERS, 2019, 11 (01):
  • [28] Preclinical investigation of anti-tumor efficacy of allogeneic natural killer cells combined with cetuximab for head and neck squamous cell carcinoma
    Kim, Chaeyeon
    Han, Mina
    Kim, Gamin
    Son, Wonrak
    Kim, Jeongah
    Gil, Minchan
    Rhee, Yong-Hee
    Sim, Nam Suk
    Kim, Chang Gon
    Kim, Hye Ryun
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2025, 74 (04)
  • [29] Identification of Anti-tumor Cells Carrying Natural Killer (NK) Cell Antigens in Patients With Hematological Cancers
    Krzywinska, Ewelina
    Allende-Vega, Nerea
    Cornillon, Amelie
    Vo, Dang-Nghiem
    Cayrefourcq, Laure
    Panabieres, Catherine
    Vilches, Carlos
    Dechanet-Merville, Julie
    Hicheri, Yosr
    Rossi, Jean-Francois
    Cartron, Guillaume
    Villalba, Martin
    EBIOMEDICINE, 2015, 2 (10): : 1364 - 1376
  • [30] Protein kinase C-θ (PKC-θ) in natural killer cell function and anti-tumor immunity
    Anel, Alberto
    Aguilo, Juan I.
    Catalan, Elena
    Garaude, Johan
    Rathore, Moeez G.
    Pardo, Julian
    Villalba, Martin
    FRONTIERS IN IMMUNOLOGY, 2012, 3
12345